3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
2
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Dermatologic
1
Classical hematology
1
Conditions
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Leukemia, Myeloid, Acute
1
Interventions
Cyclophosphamide
20
fludarabine phosphate
14
Peripheral Blood Stem Cell Transplantation
13
Dexamethasone
13
Cyclosporine
12
Whole-Body Irradiation
11
fludarabine
10
Exercise
10
Antilymphocyte Serum
10
Melphalan
9
Busulfan
9
Blood Specimen Collection
9
Mycophenolic Acid
8
Therapeutics
7
Filgrastim
7
Bortezomib
7
Standard of Care
6
Radiotherapy
6
Behavior Therapy
6
Acupuncture Therapy
6
pomalidomide
5
Specimen Handling
5
Palliative Care
5
Methotrexate
5
Granulocyte Colony-Stimulating Factor
5
Etoposide
5
Educational Status
5
daratumumab
4
Surveys and Questionnaires
4
Stem Cell Transplantation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Molecular Diagnostic Techniques
×
Plasma cell
×
Clear all
NCT02435550
2019-12-20
iCare for Cancer Patients
University of Florida
Phase NA
Terminated
136 enrolled